mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.005 |